Business | Thomson Reuters | Wednesday December 23, 2015
US health regulators on Tuesday approved AztraZeneca's drug Zurampic to treat a condition associated with gout to be used in combination with another type of drug that reduces production of uric acid in the body.
www.ndtv.com/business